24/7 Wall St. on MSN
Triple-Leveraged Biotech ETF Doubles as Regulatory Winds Shift in 2026
Triple-leveraged ETFs aren’t for everyone, but if you believe biotech is about to break out, Direxion Daily S&P Biotech Bull ...
Direxion CURE ETF offers 3x daily healthcare exposure—learn risks like volatility decay and drift, plus tactical trading tips using XLV/index signals.
Direxion Daily S&P Biotech Bear 3X Shares ETF failed to generate decent yield & price growth over the past 90 months. I don’t foresee this fund generating positive growth in the near future, either.
MarketBeat on MSN
3X-Leveraged ETFs: Amplify Returns With These 3 Top Picks
Leveraged exchange-traded funds (ETFs) substantially increase the potential reward of an investment by affording investors ...
24/7 Wall St. on MSN
Earn 8% and (Potentially) 3x the S&P’s Return This Year, but There Is a Catch
When financial stocks rally, a 3x leveraged ETF can deliver outsized gains. When they stumble, losses compound just as fast.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback